TIS 0.00% 0.0¢ tissue therapies limited

eu final clinical trial results released.., page-3

  1. rmv
    1,532 Posts.
    Tissue Therapies is also proceeding with the development of other commercial applications of various VitroGro® and other
    technologies for the treatment of psoriasis, scar prevention and potential treatments for various cancers including those of
    the breast, colon and prostate.



    For me the above bit is the most exciting bit.It means we can have growth in other areas. Psoriasis is on rise and the three cancers mentioned well its seems we all know someone who has one of them or either died from one.
    Very exciting future for TIS
 
watchlist Created with Sketch. Add TIS (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.